Lupus Erythematosus

Lupus erythematosus (LE) is an autoimmune disease characterized by chronic inflammation in which the immune system attacks the body’s own tissues. This disease can affect many organs and systems including the skin, joints, kidneys, heart, lungs, blood cells and the nervous system like. Lupus erythematosus typically follows a course of flares and remissions, and symptoms vary widely among individuals. The disease is more common in young and middle-aged women and can lead to serious complications if left untreated road.

Types of Lupus Erythematosus

Lupus erythematosus is classified into different types based on clinical features and affected organ systems. The most common types include systemic lupus erythematosus (SLE), cutaneous lupus erythematosus (CLE), and drug-induced lupus erythematosus.

Systemic Lupus Erythematosus (SLE)

Systemic lupus erythematosus (SLE) is the most common and most severe form of lupus. SLE can affect multiple organs and systems in the body. The disease typically follows a pattern of flares and remissions. Symptoms of SLE may include fatigue, joint pain, skin rashes, kidney involvement and neurological signs. SLE is characterized by the presence of autoantibodies and accumulation of immune complexes.

Cutaneous Lupus Erythematosus (CLE)

Cutaneous lupus erythematosus (CLE) is a form of lupus that primarily affects the skin. CLE usually progresses without systemic involvement, but in some patients it may evolve into SLE. The most common form of CLE is known as discoid lupus erythematosus (DLE). DLE is characterized by red, scaly lesions typically appearing on the face, scalp and ears. These lesions may leave scars after healing.

Drug-Induced Lupus Erythematosus

Drug-induced lupus erythematosus is a form of lupus triggered by the use of certain medications. These include hydralazine, procainamide and some antiepileptic drugs. Drug-induced lupus typically resolves after discontinuation of the offending medication and generally follows a milder course than systemic lupus erythematosus.

Pathophysiology of Lupus Erythematosus

Lupus erythematosus is an autoimmune disease characterized by an abnormal immune response against the body’s own tissues. In this process, autoantibodies and immune complexes cause inflammation and tissue damage. In the pathophysiology of lupus, genetic, environmental and hormonal factors important play a role.

Autoantibodies and Immune Complexes

In lupus erythematosus, autoantibodies such as antinuclear antibodies (MAIN) are frequently detected. These antibodies target components within the cell nucleus and form immune complexes. These complexes accumulate in tissues, triggering inflammation and tissue damage. Immune complexes that accumulate particularly in the kidneys can lead to serious complications such as lupus nephritis.

Genetic and Environmental Factors

Genetic susceptibility plays an important role in the development of lupus erythematosus. Certain genetic variants, such as those in the HLA (human leukocyte antigen) genes, increase the risk of lupus. Environmental factors also contribute to disease triggering. Ultraviolet (UV) radiation, infections, stress and certain medications can provoke lupus flares.

Clinical Manifestations of Lupus Erythematosus

Lupus erythematosus is a multisystemic disease that can affect numerous organs and systems. Symptoms vary depending on disease severity and the organs involved. The most common symptoms include fatigue, joint pain, skin rashes and fire.

Dermatological Findings

Dermatological manifestations are common in lupus erythematosus. The malar rash (butterfly rash) appears as a red rash across the bridge of the nose and cheeks. In discoid lupus erythematosus, red, scaly skin lesions are observed. These lesions may worsen after exposure to sun light.

Joint and Muscle Findings

Joint pain and swelling are frequent in lupus patients. Arthritis typically affects the hands and foot joints symmetrically. Kas pain and weakness are also common symptoms.

Kidney Involvement

Lupus nephritis is a serious complication of lupus erythematosus. Kidney involvement manifests as protein loss in the urine, elevated blood pressure and kidney failure. Lupus nephritis requires early diagnosis and treatment.

Neurological Findings

Lupus erythematosus can affect both the central and peripheral nervous systems. Neurological manifestations include head pain, seizures, psychosis and peripheral neuropathy. These findings may vary according to disease activity.

Diagnosis of Lupus Erythematosus

The diagnosis of lupus erythematosus is based on clinical findings and laboratory tests. Criteria established by the American College of Rheumatology (ACR) are used for diagnosis. These criteria include malar rash, discoid rash, photosensitivity, oral ulcers, arthritis, kidney involvement, neurological manifestations and hematological abnormalities.

Laboratory Tests

In diagnosing lupus, the antinuclear antibody (ANA) test is commonly used. In patients with a positive ANA test, more specific antibodies (anti-dsDNA, anti-Smith) are investigated. Additional tests include complete complete blood count, kidney function tests and urinalysis.

Treatment of Lupus Erythematosus

The treatment of lupus erythematosus is tailored according to disease severity and the organs involved. The primary goals are to control symptoms, reduce disease activity and prevent organ damage. Treatment approaches include pharmacological therapy, lifestyle modifications and patient education.

Pharmacological Therapy

Medications used in lupus treatment include nonsteroidal anti-inflammatory drugs (NSAIDs), antimalarial drugs (hydroxychloroquine), corticosteroids and immunosuppressive agents. In mild cases, NSAIDs and antimalarials may be sufficient. In severe cases, corticosteroids and immunosuppressive drugs are employed.

Lifestyle Modifications

Lupus patients should avoid sun exposure and engage in regular physical activity. A healthy diet and stress management are also important in controlling the disease. Smoking and alcohol consumption should be avoided.